Epithelial-mesenchymal transition induced by transforming growth factor-{beta}1/Snail activation aggravates invasive growth of cholangiocarcinoma - Wikidata - awgldk - TriplyDB

Epithelial-mesenchymal transition induced by transforming growth factor-{beta}1/Snail activation aggravates invasive growth of cholangiocarcinoma

Epithelial-mesenchymal transition induced by transforming growth factor-{beta}1/Snail activation aggravates invasive growth of cholangiocarcinoma

http://www.wikidata.org/entity/Q33947189

about

Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?Chronic inflammation and cytokines in the tumor microenvironment.Autophagy may promote carcinoma cell invasion and correlate with poor prognosis in cholangiocarcinoma Reelin is involved in transforming growth factor-β1-induced cell migration in esophageal carcinoma cells.Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray FoxQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMT.Pathogenesis, diagnosis, and management of cholangiocarcinoma Molecular mechanism of local drug delivery with Paclitaxel-eluting membranes in biliary and pancreatic cancer: new application for an old drug Molecular diagnosis of intrahepatic cholangiocarcinoma.E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma.TGF-β1 Reduces miR-29a Expression to Promote Tumorigenicity and Metastasis of Cholangiocarcinoma by Targeting HDAC4 CCN5/WISP-2: A micromanager of breast cancer progression The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer.Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization Epithelial-mesenchymal interactions in biliary diseases The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.Prognostic biomarkers in patients with resected cholangiocarcinoma: a systematic review and meta-analysis.Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects?Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma growth.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).TGF-β Signaling in Gastrointestinal Cancers: Progress in Basic and Clinical Research.Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma.Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma.Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis.Salinomycin enhances doxorubicin sensitivity through reversing the epithelial-mesenchymal transition of cholangiocarcinoma cells by regulating ARK5.TGF-β signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: A study on human primary cell cultures.Blocking ERK1/2 signaling impairs TGF-β1 tumor promoting function but enhances its tumor suppressing role in intrahepatic cholangiocarcinoma cells.Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies.Clinicopathological significance of S100 protein expression in cholangiocarcinoma.Role of AP-2α and MAPK7 in the regulation of autocrine TGF-β/miR-200b signals to maintain epithelial-mesenchymal transition in cholangiocarcinoma.Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview.Human antigen R mediated post-transcriptional regulation of epithelial-mesenchymal transition related genes in diabetic nephropathy.LTBP2 promotes the migration and invasion of gastric cancer cells and predicts poor outcome of patients with gastric cancer.HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancer.CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma.

P2860

Q26771988-5A8CC21C-DD4A-4439-A2F4-487F2E544441 Q33678275-23271776-6C57-4F2E-8E98-43505456FAF6 Q34121425-61351EDF-0BB5-4A40-9390-A3F3459E0D2D Q34185724-12129553-3B37-426D-AF4B-A5DA3D58D157 Q34283703-4D1DAE29-F504-4286-8F4C-76DBADE037DA Q34326636-9FBBC4A5-4D9E-494B-9FDC-3431E72A9D56 Q34656747-6FA08744-085D-459A-8F66-6DD96CE3DD49 Q35578787-116C8BCD-F3A1-48D9-BCBF-612363ED7CCE Q35592221-15EDE0A9-8248-4C69-9921-695F67E3B696 Q35653917-F008C3C4-6230-4F33-B3CE-5120AD88A1A0 Q35800600-A7C5B94E-AD19-4795-99C3-258E150FE63F Q36010510-C3910DA3-F9D1-405F-AC3F-1162F547BEC0 Q36683019-60D55CE1-BE7E-44EC-90EE-88AEDE236210 Q37121921-D5F50F25-B2AD-4E1F-A866-699C78AD6C9C Q37846143-A32C9DA1-8E39-4667-BEEF-F9BBF50EFB04 Q37964960-17B1924C-6558-4A2B-9AE0-0BEEAAD06A92 Q38148062-D99A68B2-DECF-46BC-9145-43EEB5C98522 Q38584340-247EF8F1-B0D6-408A-A8DE-9CF76F4F664A Q38728549-35F3D941-6D24-490E-91E1-CF9CCDF70350 Q38812588-18F6DDCA-C45C-4BB9-87F6-C05191F49CF0 Q39096525-0215177F-F3EF-4CFE-8750-92BECE09DFEE Q39240982-C698031C-158C-45AC-A1A3-59B38B5C55E7 Q39295117-7F9237E6-6DD0-40FC-8971-BB6111799B30 Q39775602-951F0E75-BE99-4564-8909-E3406D4B9CFD Q41452556-DCEA7243-DD46-40FA-9EDF-8A14CC6F4666 Q41617837-6235406C-8CF8-4CA8-82E4-9E0D5FC40FC5 Q41670789-39A64038-C172-4D16-B52B-2909FD640706 Q42272472-408B9C2D-4EFB-4D06-BA4C-FA86B031C74B Q45222769-852E1D83-DB60-44D6-96D4-21E6E5E03155 Q45412331-B399A5B8-029A-46B2-9224-F34DDE9A0098 Q47603972-A6F80044-2A48-4432-851E-198861FD47F9 Q51694546-38E99FA7-F15E-4617-A404-E795BF251FF8 Q52605309-16FBAF75-9C20-4021-BCD6-7EF0733DA274 Q54096044-FD0DA331-A34E-4578-8471-994BD9EF4A86 Q54967460-FFCD9C33-47C6-4A6B-A5A6-1359A7DF768E

P2860

Epithelial-mesenchymal transition induced by transforming growth factor-{beta}1/Snail activation aggravates invasive growth of cholangiocarcinoma

http://www.wikidata.org/entity/Q33947189

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Epithelial-mesenchymal transit ...... e growth of cholangiocarcinoma

@ast

Epithelial-mesenchymal transit ...... e growth of cholangiocarcinoma

@en

type

label

Epithelial-mesenchymal transit ...... e growth of cholangiocarcinoma

@ast

Epithelial-mesenchymal transit ...... e growth of cholangiocarcinoma

@en

prefLabel

Epithelial-mesenchymal transit ...... e growth of cholangiocarcinoma

@ast

Epithelial-mesenchymal transit ...... e growth of cholangiocarcinoma

@en

P1433

Q33947189-0A0C63D0-7ED6-47E9-88CF-4D43A512CB20

P1476

Q33947189-25B02FCF-EBFC-46DC-A206-9EF502404770

P2093

Q33947189-19531EB4-545F-4C9B-8B5B-25535B070541

Q33947189-367C68F0-6BC3-48EA-9793-8AAA35735446

Q33947189-40BF2AA9-5BB0-4829-BC3A-9F461BD831D1

Q33947189-461553DA-2220-48F9-BA29-54F1CD2979D8

Q33947189-516BB2C4-9522-4233-81F2-EC9C2016714A

Q33947189-5CD8FCFA-D098-4875-8189-55C8F5B09AE3

Q33947189-61CF1CBD-6668-4688-BB47-7DED1C20016B

Q33947189-6DF18891-87A9-4F3A-8B9A-0C8870E07224

Q33947189-91CBF4D7-5F8B-405A-9DFD-11FF06E8577A

Q33947189-9A0A52EB-E556-4833-8F23-D13974EF3B49

P2860

Q33947189-047B6A46-5D5B-4C4F-BD98-BC039C9A496B

Q33947189-05AC466E-742E-4096-93C3-874F74C080FB

Q33947189-15071503-308D-4976-87FF-74CC5F9B8B9B

Q33947189-1BD5100C-5AFB-443F-8377-F07223DCBDB4

Q33947189-21A90EA8-3FF5-438A-B65C-6355C23047A1

Q33947189-224C70C9-E38E-4E1D-9D10-33B34E1FA336

Q33947189-47381BA2-EED1-4C5A-9F8F-8E528148B6C3

Q33947189-4B71729B-3E93-48B4-8DB4-E8086B7F2982

Q33947189-4BAFD2D6-8D3C-4319-ABBB-02E92C4872FB

Q33947189-5581C5C1-596C-478D-8AA5-94977312FCC6

P304

Q33947189-3919F92F-57A2-4FAC-B977-202204BC15E8

P31

Q33947189-99714908-FDD7-4899-8810-30DE9A8B413C

P356

Q33947189-D9A3FB3A-5498-4D50-A098-1B40D2A87B8A

P407

Q33947189-D9655D32-1716-41C9-B9E8-93DBEF2075C3

P433

Q33947189-E508506A-1D90-4FF0-B550-F9F4A15A9487

P478

Q33947189-D6EFAB54-EADD-4118-881B-A4AF2A322B9A

P577

Q33947189-4004471F-9D28-4EBB-A6F4-3CCA4567FA6B

P5875

Q33947189-79B42222-5A7F-46C3-B574-0A8BB1C7DE74

P698

Q33947189-DAF024CB-DC53-4984-9FA7-239D2E25C6AD

P921

Q33947189-6A8311E1-EC90-4751-B8E5-4D37B074C281

P932

Q33947189-BDEC0650-B0FF-4380-9CF8-8B83D55DCD8D

P356

AJPATH.2010.090747

P1433

The American Journal of Pathology

P1476

Epithelial-mesenchymal transit ...... e growth of cholangiocarcinoma

@en

P2093

Hiroko Ikeda

http://www.w3.org/2001/XMLSchema#string

Keita Itatsu

http://www.w3.org/2001/XMLSchema#string

Kenichi Harada

http://www.w3.org/2001/XMLSchema#string

Motoko Sasaki

http://www.w3.org/2001/XMLSchema#string

Norihide Yoneda

http://www.w3.org/2001/XMLSchema#string

Syuji Shimomura

http://www.w3.org/2001/XMLSchema#string

Xiang Shan Ren

http://www.w3.org/2001/XMLSchema#string

Yasuni Nakanuma

http://www.w3.org/2001/XMLSchema#string

Yasunori Sato

http://www.w3.org/2001/XMLSchema#string

Yuko Kakuda

http://www.w3.org/2001/XMLSchema#string

P2860

The epithelial-mesenchymal transition generates cells with properties of stem cells

The epithelial-mesenchymal transition: new insights in signaling, development, and disease

Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

Complex networks orchestrate epithelial-mesenchymal transitions

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

TGF-beta and epithelial-to-mesenchymal transitions

BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo

The protective effects of estrogen on the cardiovascular system.

Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma.

P304

141-152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2010.090747

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44617698

http://www.w3.org/2001/XMLSchema#string

P698

20489148

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

2893658

http://www.w3.org/2001/XMLSchema#string